Free Trial

Seaport Res Ptn Issues Optimistic Outlook for Jushi Earnings

Jushi logo with Medical background

Key Points

  • Analysts at Seaport Res Ptn have revised their Q4 2025 earnings per share estimate for Jushi Holdings Inc. to ($0.05), up from ($0.06).
  • Jushi's stock has decreased by 14.7%, currently trading at $0.68, with a 12-month highest value of $0.98.
  • In its last quarterly report, Jushi posted a revenue of $65.05 million, matching analysts' expectations of ($0.06) EPS for the quarter.
  • Five stocks to consider instead of Jushi.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Equities researchers at Seaport Res Ptn lifted their Q4 2025 earnings per share (EPS) estimates for Jushi in a note issued to investors on Sunday, August 10th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will earn ($0.05) per share for the quarter, up from their prior estimate of ($0.06). The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Seaport Res Ptn also issued estimates for Jushi's Q2 2026 earnings at ($0.04) EPS and FY2026 earnings at ($0.19) EPS.

Jushi (OTCMKTS:JUSHF - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.06) EPS for the quarter, meeting analysts' consensus estimates of ($0.06). The business had revenue of $65.05 million during the quarter, compared to analyst estimates of $64.67 million.

Jushi Price Performance

JUSHF traded up $0.03 during trading hours on Wednesday, reaching $0.62. The company's stock had a trading volume of 900,318 shares, compared to its average volume of 246,342. Jushi has a fifty-two week low of $0.22 and a fifty-two week high of $0.98. The stock has a market cap of $121.46 million, a PE ratio of -2.13 and a beta of -0.98. The business's 50-day moving average is $0.43 and its 200-day moving average is $0.36.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Featured Stories

Earnings History and Estimates for Jushi (OTCMKTS:JUSHF)

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.